Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Classification & Diagnosis of Granulomatosis with Polyangiitis

Harry E. Subramanian, Ravi Sutaria, MD, & Fotios Koumpouras, MD  |  Issue: August 2018  |  August 16, 2018

During her hospitalization, the patient developed an acute kidney injury, with her creatinine rising to 2.1 mg/dL from 0.7 mg/dL on presentation. Further laboratory testing revealed an elevated erythrocyte sedimentation rate (ESR) of 78 mm/hr (ref: 0–20) and C-reactive protein (CRP) of 12.7 mg/L (ref: 0.1–3.0), a rheumatoid factor of 41 IU/mL (ref: <14) and a positive C-ANCA with a titer >1:160.

The patient’s presentation with pulmonary hemorrhage, acute kidney injury and high C-ANCA titer led to a diagnosis of GPA. She was treated with pulse dose steroids for three days and concurrently started on plasma exchange, of which two cycles were completed. She was then placed on 240 mg/day of methylprednisolone.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Twelve days after her initial presentation, the patient was transferred to our institution to obtain a renal biopsy. On arrival, she was intubated and afebrile with a heart rate of 123 beats per minute and a blood pressure of 143/72 mmHg. Examination demonstrated a III/VI systolic murmur heard across the precordium, as well as splinter hemorrhages and purpuric periungual lesions in several bilateral fingers and toes, and peripheral edema in bilateral upper and lower extremities.

Her laboratory studies were notable for a total leukocyte count of 21,000 cells/μL and a creatinine of 2.0 mg/dL. Her complement levels were decreased, with a C3 of 31 mg/dL (ref: 81–145) and C4 <10 mg/dL (ref: 16–39), but her C1Q was 14 mg/dL (ref: 12–22), which was within normal range. Her ESR was 4 mm/hr (ref: 0–20), CRP was 14 mg/L (ref: 0.1–3.0), and fibrinogen was 83 mg/dL (ref: 144–436). Her ANCA screen was positive for C-ANCA, with a titer of 1:80 (ref: <1:20) and a PR3 antibody level of 606.9 CU (ref: <20). Her rheumatoid factor level was elevated at 18 IU/mL (ref: <15.9). Tests for ANA, anti-cardiolipin antibodies, anti-beta-2 glycoprotein antibodies and anti-glomerular basement membrane (GBM) antibodies were negative. A urinalysis revealed cloudy urine with a specific gravity of 1.012, 1+ protein, 3+ blood, and three to five red blood cells per high-power field. Further urine testing revealed a urine protein to creatinine ratio of 1.31.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A chest X-ray demonstrated hazy perihilar opacities and small bilateral pleural effusions, and a chest CT scan demonstrated an upper lobe predominant diffuse opacification that was consistent with pulmonary hemorrhage (see Figure 1). The patient was continued on a one-month antibiotic regimen of vancomycin and ceftriaxone and also maintained on 240 mg/day of methylprednisolone. Further immunosuppressive agents were not started due to concern for infective endocarditis.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:ANCAantineutrophil cytoplasmic antibodyGPAgranulomatosis with polyangiitis

Related Articles
    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

    October 18, 2019

    Apremilast was first marketed in March 2014 for the treatment of adults with psoriatic arthritis (PsA). An immuno­modulating drug, which is a small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine mono­phosphate (cAMP), apremilast is administered orally. By inhibiting PDE4, intracellular cAMP levels are increased. Although the exact mechanism of action is not…

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences